Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 552

Results For "US"

8889 News Found

InnoCare gets approval of clinical trial of Zurletrectinib for the treatment of pediatric patients in China
News | July 26, 2023

InnoCare gets approval of clinical trial of Zurletrectinib for the treatment of pediatric patients in China

Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes


Robotic surgery enhances success rate in knee replacements
Healthcare | July 26, 2023

Robotic surgery enhances success rate in knee replacements

Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%


Adlib and Generis launch software connector to increases automation and compliant management of document repositories
Digitisation | July 26, 2023

Adlib and Generis launch software connector to increases automation and compliant management of document repositories

CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes


TransCure bioServices partners with Preclina to expands reach into APAC
Biotech | July 26, 2023

TransCure bioServices partners with Preclina to expands reach into APAC

Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders


Teva Pharmaceuticals engages Honeywell to help reduce carbon impact
Sustainability | July 26, 2023

Teva Pharmaceuticals engages Honeywell to help reduce carbon impact

Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model


Syngene Q1 FY 2024 revenue up 26% to Rs. 832 crores, PAT up 26% to Rs.93 Cr
News | July 26, 2023

Syngene Q1 FY 2024 revenue up 26% to Rs. 832 crores, PAT up 26% to Rs.93 Cr

Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24


AstraZeneca India receives permission from DCGI for Dapagliflozin
Drug Approval | July 25, 2023

AstraZeneca India receives permission from DCGI for Dapagliflozin

The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca


Need to strengthen food safety scientific standards: NITI Aayog
Policy | July 24, 2023

Need to strengthen food safety scientific standards: NITI Aayog

There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits